Antiangiogenesis in cancer therapy--endostatin and its mechanisms of action.
about
Endorepellin laminin-like globular 1/2 domains bind Ig3-5 of vascular endothelial growth factor (VEGF) receptor 2 and block pro-angiogenic signaling by VEGFA in endothelial cellsResponse gene to complement 32, a novel hypoxia-regulated angiogenic inhibitorThe first draft of the endostatin interaction networkOncosuppressive functions of decorinProteoglycans in liver cancerCorrelation of serum levels of endostatin with tumor stage in gastric cancer: a systematic review and meta-analysisDevelopmental and pathological angiogenesis in the central nervous systemCrystal Structure of Human Collagen XVIII Trimerization Domain: A Novel Collagen Trimerization FoldPhysiological, pathological, and structural implications of non-enzymatic protein-protein interactions of the multifunctional human transglutaminase 2RNA-binding protein nucleolin in diseaseSynergistic antitumor effects of endostar in combination with oxaliplatin via inhibition of HIF and CXCR4 in the colorectal cell line SW1116Digoxin suppresses HIV-1 replication by altering viral RNA processingAntiangiogenic treatment diminishes renal injury and dysfunction via regulation of local AKT in early experimental diabetesComprehensive evaluation of the anti-angiogenic and anti-neoplastic effects of Endostar on liver cancer through optical molecular imagingManagement of treatment-associated toxicites of anti-angiogenic therapy in patients with brain tumors.An experimental research into endostatin microbubble combined with focused ultrasound for anti-tumor angiogenesis in colon cancer.Fog2 is critical for cardiac function and maintenance of coronary vasculature in the adult mouse heart.Dimerization of VEGF receptors and implications for signal transduction: a computational study.Novel Phenotypic Fluorescent Three-Dimensional Platforms for High-throughput Drug Screening and Personalized Chemotherapy.Medoidshift clustering applied to genomic bulk tumor data.Erythropoietin blockade inhibits the induction of tumor angiogenesis and progression.Neostatin-7 regulates bFGF-induced corneal lymphangiogenesis[Efficacy and safety of rh-endostatin combined with chemotherapy versus chemotherapy alone for advanced NSCLC: a meta-analysis review].Indolyl-quinuclidinols inhibit ENOX activity and endothelial cell morphogenesis while enhancing radiation-mediated control of tumor vasculature.Serum Biomarkers of Myocardial Remodeling and Coronary Dysfunction in Early Stages of Hypertrophic Cardiomyopathy in the Young.Genetically engineered endostatin-lidamycin fusion proteins effectively inhibit tumor growth and metastasis.Multicenter randomized phase 2 clinical trial of a recombinant human endostatin adenovirus in patients with advanced head and neck carcinomaPhase I trial of M2ES, a novel polyethylene glycosylated recombinant human endostatin, plus gemcitabine in advanced pancreatic cancer.Targeting the tumor microenvironment.Progress on antiangiogenic therapy for patients with malignant glioma.Microvascular rarefaction: the decline and fall of blood vesselsRecombined humanized endostatin (Endostar) combined with chemotherapy for advanced bone and soft tissue sarcomas in stage IV.Proteomic screening of anaerobically regulated promoters from Salmonella and its antitumor applications.Effects of recombinant human canstatin protein in the treatment of pancreatic cancerPotential relevance of bell-shaped and u-shaped dose-responses for the therapeutic targeting of angiogenesis in cancerBrucine suppresses colon cancer cells growth via mediating KDR signalling pathway.Investigation of antiangiogenic tumor therapy potential of microencapsulated HEK293 VEGF165b producing cells.Anti-angiogenic treatment strategies for the therapy of endometriosis.Serum endostatin levels are elevated in colorectal cancer and correlate with invasion and systemic inflammatory markers.Recombinant human endostatin could eliminate the pro-angiogenesis priority of SP cells sorted from non-small cell lung cancer cells.
P2860
Q24312922-622D1AD9-F021-49E1-932E-84E48FE1FD9EQ24320745-E34F9336-6E0C-4BC0-B49D-45F4203F1B23Q24338820-E517F4E3-8D75-4BA7-95DE-3197D69191A7Q26745697-A112588E-188E-49E6-8846-40655FC8D4ABQ26772304-A5307640-267F-49D7-858E-3AC1FE95E3F2Q27002610-A63E60E7-2EA9-4F8E-8996-D9DC264E2BE3Q27023250-D7BCB7A0-7BAF-4D4F-BCCE-E3CE149AEF6DQ27656720-BD6F283A-C205-4DFD-99D0-7A313348176FQ28261578-CBD34BD1-A737-4DE2-946B-2849E8A2D490Q28390879-7FDE9BCE-D754-49FB-851B-9D95E187931EQ28484315-7315E6C7-6194-4A33-A2CE-74068BA11249Q28489086-6A9C1BB9-8B33-43A1-915B-056BCCE9B01CQ28538183-B19B316B-0540-414F-8A56-4EDD36874330Q28538538-E5C827C8-55EB-4616-828B-C029B7DCCE63Q30417015-E58B0E4C-8979-4CF5-B585-F42648FD23EEQ30443142-19E38E17-8868-42C6-B13E-753A3C02F43DQ30487913-18ED9B35-3B34-4C0B-8163-6115C33FDAFFQ30488864-7862E76E-04D6-4BE4-B7ED-D0DCDD4F6075Q30541176-B4FC07E7-5E80-43EC-8C27-F9931D4DD975Q31040446-85323093-240C-4994-88D3-1623766EF9F2Q33288270-72303B70-285C-4836-B343-1827C8370D39Q33345623-EE81DFC3-16B7-4837-93AA-EE60AF0E144BQ33395300-7EF594C6-AD43-4CA0-B7CD-BD7A90C8FE11Q33552232-83589A95-EB77-40A8-80FB-6384B5CF9B37Q33554999-D59CEFF8-ACB1-4C6B-B9B6-715B61EE965DQ33592796-47111DFA-AF2E-4AB5-ADAA-3D44E288C2ABQ33724272-885FDD6F-2097-4D6F-B605-EC2D56CE0BF7Q33733758-0026F8E9-6FE7-4EC7-9D80-C64FFB02AB7DQ33736691-0A1E8C46-5EB8-4F01-B6C9-8B73AE953BA9Q33773189-2D47BF8F-D1F6-4018-B71C-F6DA88233D0FQ33818980-900EA078-1752-4E8D-9828-DDC470C90433Q33829625-5B1ACB55-06A8-468D-B45B-2D58B7030A26Q33865605-91D38D3F-A027-4532-9A7B-9E8190E873FFQ34017753-11F1CE45-24F4-49B0-ACF2-5C45B6280995Q34128953-384ACC03-7881-43A1-BBA7-652602C17005Q34154752-C9A1F414-5438-436B-8E92-6E1115D646B6Q34210916-C4015766-B4B4-45A3-8116-7F3B6A7FECDFQ34283036-794B6CEE-2BB2-41C0-954D-069616132753Q34354606-30391B9B-8EE5-4DC0-B302-A15435FC87AFQ34362205-44896536-8697-4BDD-A959-2030B45DCAE1
P2860
Antiangiogenesis in cancer therapy--endostatin and its mechanisms of action.
description
2005 nî lūn-bûn
@nan
2005 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Antiangiogenesis in cancer therapy--endostatin and its mechanisms of action.
@ast
Antiangiogenesis in cancer therapy--endostatin and its mechanisms of action.
@en
Antiangiogenesis in cancer therapy--endostatin and its mechanisms of action.
@nl
type
label
Antiangiogenesis in cancer therapy--endostatin and its mechanisms of action.
@ast
Antiangiogenesis in cancer therapy--endostatin and its mechanisms of action.
@en
Antiangiogenesis in cancer therapy--endostatin and its mechanisms of action.
@nl
prefLabel
Antiangiogenesis in cancer therapy--endostatin and its mechanisms of action.
@ast
Antiangiogenesis in cancer therapy--endostatin and its mechanisms of action.
@en
Antiangiogenesis in cancer therapy--endostatin and its mechanisms of action.
@nl
P1476
Antiangiogenesis in cancer therapy--endostatin and its mechanisms of action.
@en
P2093
Judah Folkman
P304
P356
10.1016/J.YEXCR.2005.11.015
P407
P577
2005-12-22T00:00:00Z